Date published: 2026-5-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

E6BP Inhibitors

The chemical class identified as E6BP Inhibitors refers to compounds that can modulate the activity of E6BP, also known as Calcyclin Binding Protein or CACYBP. E6BP plays a pivotal role in a range of cellular processes, primarily involving protein interactions and signaling pathways. These inhibitors function not by directly targeting the E6BP protein itself, but by influencing the cellular processes and pathways in which E6BP is a critical participant. This method leverages the interconnected nature of cellular functions, where modifying one aspect can have cascading effects on others, including E6BP. The approach of these inhibitors is to alter processes such as protein degradation pathways, signaling cascades involving E6BP, and interactions that E6BP mediates, thereby impacting its role within the cell.

The efficacy of E6BP inhibitors stems from their ability to interfere with specific cellular activities central to E6BP's functionality. E6BP is involved in the ubiquitin-proteasome system, playing a role in the targeted degradation of proteins. Compounds that affect this pathway can thereby influence E6BP's role in protein turnover. Additionally, E6BP is a part of various protein complexes and interacts with several signaling molecules, including those in the Wnt/β-catenin pathway. By modulating these interactions, E6BP inhibitors can affect the signaling processes in which E6BP is involved. This impact is crucial because E6BP's interactions are significant for several cellular functions, including cell cycle regulation, signal transduction, and possibly tumorigenesis. The class of E6BP inhibitors is an area of interest in cellular biology and biochemistry due to its potential to shed light on the intricate mechanisms of protein interactions and cellular signaling pathways. Their varied mechanisms of action highlight the complexities involved in targeting specific proteins and their associated cellular roles. These inhibitors demonstrate the potential of modulating protein-protein interactions and signaling pathways to alter the activity of key proteins like E6BP. The capability to influence processes associated with E6BP offers insights into the fundamental aspects of cell biology, particularly how proteins interact within cells to regulate various processes and maintain cellular homeostasis. By targeting the interactions and pathways involving E6BP, these inhibitors provide a means to explore and potentially modulate critical cellular functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin could possibly inhibit E6BP by inducing ER stress through the inhibition of the ER calcium ATPase, affecting calcium regulation.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin could possibly inhibit E6BP by inducing ER stress and impacting protein folding, due to its inhibition of N-linked glycosylation.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A could possibly inhibit E6BP by disrupting ER-Golgi transport, affecting protein processing roles of RCN2.

Dantrolene

7261-97-4sc-500165
25 mg
$350.00
7
(0)

Dantrolene could possibly inhibit E6BP by modulating calcium release from the ER, impacting calcium-binding functions.

Ryanodine

15662-33-6sc-201523
sc-201523A
1 mg
5 mg
$223.00
$799.00
19
(2)

Ryanodine could possibly inhibit E6BP by altering calcium release from the ER, which can influence calcium regulation.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

2-APB could possibly inhibit E6BP by modulating calcium signaling, impacting RCN2's role in ER calcium homeostasis.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin could possibly inhibit E6BP by increasing intracellular calcium concentration, affecting calcium-binding activities.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187, an ionophore, could possibly inhibit E6BP by increasing intracellular calcium, influencing calcium regulation.

Cyclopiazonic Acid

18172-33-3sc-201510
sc-201510A
10 mg
50 mg
$176.00
$624.00
3
(1)

Cyclopiazonic Acid could possibly inhibit E6BP by inhibiting the ER calcium ATPase, impacting calcium homeostasis in the ER.